HKSTP showcases Hong Kong's Innovation and Technology edge

Japan |  News | 0 Comment | 02 Nov, 2018

Hong Kong Science and Technology Parks Corporation (HKSTP) announced its fruitful participation in promoting Hong Kong's innovation and technology (I&T) edge at the annual&nbs...Read more

Kissei buys exclusive rights of Tavalisse in Asian countries

Japan |  News | 0 Comment | 01 Nov, 2018

Japanese drugmaker Kissei Pharmaceutical has acquired exclusive rights to develop and commercialize Tavalisse (fostamatinib disodium) in all current and potential indications in Japan, Chin...Read more

Green Science Alliance starts production of Chitin, Chitosan Nanofiber

Japan |  News | 0 Comment | 30 Oct, 2018

Chitin nanofiber is a new material made from crab shells. In brief, it can be prepared by making chitin on a nanoscale. Chitin nanofibers have high mechanical strength, high elasticity, and...Read more

Mitsui Chemicals, Chitose Group launch novel open innovation initiative

Japan |  News | 0 Comment | 30 Oct, 2018

Mitsui Chemicals, Inc. and Chitose Group, a group of biotechnology startups have jointly launched the "0 to 1 Project" as a novel open innovation initiative to foster business and talents b...Read more

NEC, Transgene collaborate for individualized cancer immunotherapy

Japan |  News | 0 Comment | 30 Oct, 2018

NEC Corporation and Transgene have announced the signing of a Memorandum of Understanding (MoU) for a strategic collaboration aimed at the treatment of solid cancers. The companies will coo...Read more

Daiichi enters clinical collaboration with Merck, Pfizer

Japan |  News | 0 Comment | 27 Oct, 2018

Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer, Inc. to evaluate the combination ...Read more

Mesoblast licensee seeks expanded indication for stem cell product in Japan

Japan |  News | 0 Comment | 24 Oct, 2018

Singapore –  Mesoblast announces that Japanese licensee JCR Pharmaceuticals Co. Ltd. plans to seek a new indication for its mesenchymal stem cell product, branded as TEMCELL...Read more

J & J announces Offer to Acquire Ci:z Holdings Co., Ltd.

Japan |  News | 0 Comment | 23 Oct, 2018

Johnson & Johnson has announced that they have agreed with Ci:z Holdings Co., Ltd. a Japanese company focused on the marketing, development and distribution of a broad range of dermocos...Read more

Eisai, MSD start marketing activity for LENVIMA

Japan |  News | 0 Comment | 23 Oct, 2018

Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., have announced that the two companies have commenced joint medical and marketing activities fo...Read more

Anaeropharma, Chugai come together to create Novel Oncology Drugs

Japan |  News | 0 Comment | 22 Oct, 2018

Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo have concluded a collaborative research agreement concerning the creation of novel oncology drugs utiliz...Read more

Eisai discovers new compound to treat Parkinson's disease

Japan |  News | 0 Comment | 19 Oct, 2018

A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physiology of the Keio University School of Medicine, together with a rese...Read more

Daiichi Sankyo submits NDA in Japan for leukemia drug

Japan |  News | 0 Comment | 17 Oct, 2018

Daiichi Sankyo Company,  recently announced that it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labor and Welfare (MHLW) for marketing approval of q...Read more

Eisai, Purdue Pharma declare positive results of SUNRISE 2

Japan |  News | 0 Comment | 17 Oct, 2018

Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sle...Read more

Eisai signs pact with Eurofarma for anti-obesity agent

Japan |  News | 0 Comment | 16 Oct, 2018

Eisai Co., Ltd. has entered into an agreement with Eurofarma Laboratorios, to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in 17 coun...Read more

Hitachi's heavy ion beam therapy system starts treatment at Osaka

Japan |  News | 0 Comment | 16 Oct, 2018

Hitachi, Ltd. announced that its heavy ion beam therapy system has started treatment at Osaka Heavy Ion Therapy Center as of October 16. This marks the first operation of Hitachi's first he...Read more

Innovus Pharma receives approval from Amazon for expansion in Japan

Japan |  News | 0 Comment | 15 Oct, 2018

Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men...Read more

GHIT Fund partners with Ono Pharmaceutical

Japan |  News | 0 Comment | 15 Oct, 2018

The Global Health Innovative Technology (GHIT) Fund has welcomed Ono Pharmaceutical Co., Ltd. (Ono) to join GHIT as a new affiliate partner. Ono, headquartered in Osaka, Japan, is a re...Read more

Scientists develop in vivo skin imaging technology

Japan |  News | 0 Comment | 13 Oct, 2018

A team of scientists from Tohoku University in collaboration with Advantest has developed in vivo skin imaging technology that can simultaneously generate dual-wavelength photoacoustic imag...Read more